Nippon India Pharma Fund vs Kotak Healthcare Fund compare
Kotak Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹464 Cr | ₹8114 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 11 Dec 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.39 | 1.82 |
| Manager | Abhishek Bisen | Sailesh Raj Bhan |
| ISIN Code | INF174KA1PW4 | INF204K01968 |
| Exits Load | Kotak Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | 2.65% | 2.16% |
| 6 Month | 4.87% | 3.03% |
| 1 Year | -0.86% | -0.53% |
| 3 Year | - | 20.87% |
| 5 Year | - | 18.19% |
SIP Return Analysis
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -0.37% | -1.64% |
| 1 Year | 1.21% | 0.85% |
| 3 Year | - | 16.65% |
| 5 Year | - | 15.98% |
Rolling Lumpsum Returns
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 13.51% | 16.99% |
| 3 Year | - | 20.8% |
| 5 Year | - | 20.54% |
Risk Management
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 15.24% |
| Sharp | - | 0.90% |
| Beta | - | 0.91% |
| Alpha | - | -0.55% |
Fund Managers
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Abhishek Bisen | Sailesh Raj Bhan |
| Total AUM | ₹0 Cr | ₹96086 Cr |
| Funds Managed | 33 | 5 |
| Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 9.77 | 1.52 |
| Large Cap | 27.79 | 33.27 |
| Mid Cap | 31.93 | 33.86 |
| Small Cap | 30.51 | 31.35 |
Sector Allocation
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 2.32 | 0.53 |
| Basic Materials | 2.56 | - |
| Healthcare | 95.12 | 99.47 |
Top Comparisons
Tata Ethical Fund-Regular Plan - Growth Option
3Y Returns10.92%
Axis Quant Fund - Regular Plan - Growth
3Y Returns12.05%
Kotak Large & Midcap Fund - Growth
3Y Returns18.8%
Sundaram Large and Midcap Fund Regular Plan - Growth
3Y Returns16.3%
Tata Overnight Fund-Regular Plan-Growth
3Y Returns6.34%
UTI - Overnight Fund - Regular Plan - Growth Option
3Y Returns6.39%
Nippon India Medium to Long Duration Fund - Growth Plan - Growth Option
3Y Returns6.93%
Canara Robeco Income Fund - Regular Plan - Growth Option
3Y Returns6.25%